Historical Valuation
Hims & Hers Health Inc (HIMS) is now in the Fair zone, suggesting that its current forward PS ratio of 2.87 is considered Fairly compared with the five-year average of 1.70. The fair price of Hims & Hers Health Inc (HIMS) is between 11.72 to 58.82 according to relative valuation methord.
Relative Value
Fair Zone
11.72-58.82
Current Price：31.69
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Hims & Hers Health Inc (HIMS) has a current Price-to-Book (P/B) ratio of 13.08. Compared to its 3-year average P/B ratio of 11.36 , the current P/B ratio is approximately 15.13% higher. Relative to its 5-year average P/B ratio of 7.77, the current P/B ratio is about 68.41% higher. Hims & Hers Health Inc (HIMS) has a Forward Free Cash Flow (FCF) yield of approximately 1.76%. Compared to its 3-year average FCF yield of 1.63%, the current FCF yield is approximately 8.25% lower. Relative to its 5-year average FCF yield of 0.06% , the current FCF yield is about 2968.63% lower.
P/B
Median3y
11.36
Median5y
7.77
FCF Yield
Median3y
1.63
Median5y
0.06
Competitors Valuation Multiple
AI Analysis for HIMS
The average P/S ratio for HIMS competitors is 1.54, providing a benchmark for relative valuation. Hims & Hers Health Inc Corp (HIMS.N) exhibits a P/S ratio of 2.87, which is 86.61% above the industry average. Given its robust revenue growth of 49.16%, this premium appears sustainable.
Performance Decomposition
AI Analysis for HIMS
1Y
3Y
5Y
Market capitalization of HIMS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HIMS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HIMS currently overvalued or undervalued?
Hims & Hers Health Inc (HIMS) is now in the Fair zone, suggesting that its current forward PS ratio of 2.87 is considered Fairly compared with the five-year average of 1.70. The fair price of Hims & Hers Health Inc (HIMS) is between 11.72 to 58.82 according to relative valuation methord.
What is Hims & Hers Health Inc (HIMS) fair value?
HIMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Hims & Hers Health Inc (HIMS) is between 11.72 to 58.82 according to relative valuation methord.
How does HIMS's valuation metrics compare to the industry average?
The average P/S ratio for HIMS's competitors is 1.54, providing a benchmark for relative valuation. Hims & Hers Health Inc Corp (HIMS) exhibits a P/S ratio of 2.87, which is 86.61% above the industry average. Given its robust revenue growth of 49.16%, this premium appears sustainable.
What is the current P/B ratio for Hims & Hers Health Inc (HIMS) as of Jan 10 2026?
As of Jan 10 2026, Hims & Hers Health Inc (HIMS) has a P/B ratio of 13.08. This indicates that the market values HIMS at 13.08 times its book value.
What is the current FCF Yield for Hims & Hers Health Inc (HIMS) as of Jan 10 2026?
As of Jan 10 2026, Hims & Hers Health Inc (HIMS) has a FCF Yield of 1.76%. This means that for every dollar of Hims & Hers Health Inc’s market capitalization, the company generates 1.76 cents in free cash flow.
What is the current Forward P/E ratio for Hims & Hers Health Inc (HIMS) as of Jan 10 2026?
As of Jan 10 2026, Hims & Hers Health Inc (HIMS) has a Forward P/E ratio of 56.69. This means the market is willing to pay $56.69 for every dollar of Hims & Hers Health Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Hims & Hers Health Inc (HIMS) as of Jan 10 2026?
As of Jan 10 2026, Hims & Hers Health Inc (HIMS) has a Forward P/S ratio of 2.87. This means the market is valuing HIMS at $2.87 for every dollar of expected revenue over the next 12 months.